Angiodynamic Inc
Angiodynamic Inc (ANGO) Implied Volatility Current
ANGO implied volatility is 107%. IV Rank is 94%, placing current premiums in the top of their 52-week range.
Read more
Tracking ANGO implied volatility helps you identify when options premiums on Angiodynamic Inc are historically cheap or expensive, and where the best trades are hiding. Angiodynamic Inc implied volatility reflects the market's expectation of future price movement: when ANGO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Angiodynamic Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANGO, tracking metrics like ANGO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANGO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits.
In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANGO implied volatility sits today versus where it has been. Our scanner ranks Angiodynamic Inc implied volatility against its historical range, surfaces extremes in ANGO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Angiodynamic Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 16, 2026
Trade options with IV on your side
Track ANGO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→